Ambiq Micro, Inc. (AMBQ) - 10-K Summary
Business Context and Reporting Period
This Annual Report on Form 10-K covers the fiscal year ended December 31, 2025. Ambiq Micro, Inc. is a fabless semiconductor company specializing in ultra-low power solutions for edge AI devices, utilizing its proprietary Sub-threshold Power Optimized Technology (SPOT) platform. The company completed its Initial Public Offering (IPO) on July 31, 2025, listing on the New York Stock Exchange under the symbol "AMBQ." As of December 31, 2025, the company had 202 employees and operates as an "emerging growth company" and "smaller reporting company."
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Sales | $72.5 million | $76.1 million |
| Gross Profit | $32.1 million | $24.3 million |
| Gross Margin | 44.3% | 31.9% |
| Net Loss | $(36.5) million | $(39.7) million |
| Operating Cash Flow | $(19.7) million | $(21.4) million |
| Cash and Cash Equivalents (Year End) | $140.3 million | $61.0 million |
| Accumulated Deficit | $(356.7) million | $(320.3) million |
Liquidity: The company raised $102.7 million in net proceeds from its IPO in July 2025 and an additional $76.8 million from a follow-on offering in January 2026 (subsequent event). Management believes current cash resources are sufficient to fund operations for at least the next 12 months.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 4.7% to $72.5 million, driven by a strategic shift away from Mainland China customers (sales dropped from 50% of total in 2024 to 8.6% in 2025) to prioritize higher-margin markets in the U.S. and Europe.
- Margin Expansion: Gross margin improved significantly by 1,240 basis points to 44.3%, attributed to the mix shift toward higher-value customers outside of Mainland China and improved product mix.
- Expense Growth: Selling, General, and Administrative (SG&A) expenses increased 19.5% to $33.2 million, primarily due to $2.5 million in IPO transaction costs, increased stock-based compensation, and public company compliance costs. R&D expenses remained relatively flat, increasing 3.5% to $38.5 million.
- Customer Concentration: The top three end customers accounted for approximately 85% of net sales in 2025 (35.6%, 28.8%, and 20.2% respectively), indicating high concentration risk.
Outlook, Risks, and Management Commentary
Strategy: Management is focused on expanding into new edge AI markets (medical, industrial, smart home) and introducing new products like the "Atomiq" family to support more compute-intensive AI workloads. The company aims to diversify revenue streams through IP licensing of its SPOT platform.
Risks and Contingencies:
- Customer Concentration: Heavy reliance on a limited number of end customers; loss of a major customer could materially impact revenue.
- Supply Chain: The company relies on a single supplier, TSMC, for all wafer fabrication. Geopolitical tensions involving Taiwan pose a significant risk.
- Profitability: The company has a history of net losses and expects to continue incurring losses as it invests in R&D and market expansion. There is no guarantee of future profitability.
- Regulatory: Subject to evolving AI regulations (e.g., EU AI Act) and export controls, particularly regarding sales to entities in Mainland China (e.g., Huawei, which accounted for 41% of sales in 2024 but only 0.1% in 2025).
- Internal Controls: A material weakness in internal controls identified in 2024 regarding segregation of duties was remediated as of December 31, 2025.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the top three customers, which collectively represent ~85% of revenue.
- Geographic Shift: Assess the sustainability of the margin improvement driven by the exit from Mainland China markets and the ability to replace lost volume with U.S./European demand.
- Supply Chain Resilience: Evaluate the risks associated with sole-source reliance on TSMC for wafer fabrication.
- Cash Burn Rate: Monitor operating cash flow usage against the $140.3 million cash balance to determine runway before additional financing is required.
- Product Pipeline: Track the development and commercialization timeline of the "Atomiq" product line and new IP licensing initiatives.